Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients

Transplant Proc. 1996 Feb;28(1):50-1.

Authors

M Durlik¹, Z Gaciong, L Soluch, B Walecka-Zielecka, Z Rancewicz, D Rowińska, W Rowiński, J Szmidt, M Lao

Affiliation

¹ Transplantation Institute, Warsaw Medical School, Poland.

PMID: 8644327

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Female
Follow-Up Studies
Hepatitis B Surface Antigens / blood*
Hepatitis C Antibodies / blood*
Hepatitis, Viral, Human / epidemiology*
Hepatitis, Viral, Human / mortality
Histocompatibility Testing
Humans
Kidney Transplantation* / immunology
Kidney Transplantation* / mortality
Male
Middle Aged
Postoperative Complications / epidemiology
Retrospective Studies
Time Factors

Substances

Hepatitis B Surface Antigens
Hepatitis C Antibodies